Literature DB >> 20028137

Identification of the binding site for the regulatory calcium-binding domain in the catalytic domain of NOX5.

Fabiana Tirone1, Laura Radu, Constantin T Craescu, Jos A Cox.   

Abstract

NADPH oxidases (NOX) are important superoxide producing enzymes that regulate a variety of physiological and pathological processes such as bacteria killing, angiogenesis, sperm-oocyte fusion, and oxygen sensing. NOX5 is a member of the NOX family but distinct from the others by the fact that it contains a long N-terminus with four EF-hand Ca(2+)-binding sites (NOX5-EF). NOX5 generates superoxide in response to intracellular Ca(2+) elevation in vivo and in a cell-free system. Previously, we have shown that the regulatory N-terminal EF-hand domain interacts directly and in a Ca(2+)-dependent manner with the catalytic C-terminal catalytic dehydrogenase domain (CDHD) of the enzyme, leading to its activation. Here we have characterized the interaction site for the regulatory NOX5-EF in the catalytic CDHD of NOX5 using cloned fragments and synthetic peptides of the CDHD. The interaction was monitored with pull-down techniques, cross-linking experiments, tryptophan fluorescence, hydrophobic exposure, isothermal titration calorimetry, and cell-free system enzymatic assays. This site is composed of two short segments: the 637-660 segment, referred to as the regulatory EF-hand-binding domain (REFBD), and the 489-505 segment, previously identified as the phosphorylation region (PhosR). NOX5-EF binds to these two segments in a Ca(2+)-dependent way, and the superoxide generation by NOX5 depends on this interaction. Controlled proteolysis suggests that the REFBD is autoinhibitory and inhibition is relieved by NOX5-EF.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20028137     DOI: 10.1021/bi901846y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  23 in total

1.  Ebselen and congeners inhibit NADPH oxidase 2-dependent superoxide generation by interrupting the binding of regulatory subunits.

Authors:  Susan M E Smith; Jaeki Min; Thota Ganesh; Becky Diebold; Tsukasa Kawahara; Yerun Zhu; James McCoy; Aiming Sun; James P Snyder; Haian Fu; Yuhong Du; Iestyn Lewis; J David Lambeth
Journal:  Chem Biol       Date:  2012-06-22

2.  Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse.

Authors:  Jay C Jha; Aozhi Dai; Chet E Holterman; Mark E Cooper; Rhian M Touyz; Chris R Kennedy; Karin A M Jandeleit-Dahm
Journal:  Diabetologia       Date:  2019-06-20       Impact factor: 10.122

Review 3.  Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.

Authors:  Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Circ Res       Date:  2012-05-11       Impact factor: 17.367

4.  Biomechanical Forces and Oxidative Stress: Implications for Pulmonary Vascular Disease.

Authors:  Evgeny A Zemskov; Qing Lu; Wojciech Ornatowski; Christina N Klinger; Ankit A Desai; Emin Maltepe; Jason X-J Yuan; Ting Wang; Jeffrey R Fineman; Stephen M Black
Journal:  Antioxid Redox Signal       Date:  2019-03-19       Impact factor: 8.401

Review 5.  Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling.

Authors:  Imad Al Ghouleh; Nicholas K H Khoo; Ulla G Knaus; Kathy K Griendling; Rhian M Touyz; Victor J Thannickal; Aaron Barchowsky; William M Nauseef; Eric E Kelley; Phillip M Bauer; Victor Darley-Usmar; Sruti Shiva; Eugenia Cifuentes-Pagano; Bruce A Freeman; Mark T Gladwin; Patrick J Pagano
Journal:  Free Radic Biol Med       Date:  2011-06-14       Impact factor: 7.376

Review 6.  Nox Inhibitors & Therapies: Rational Design of Peptidic and Small Molecule Inhibitors.

Authors:  M Eugenia Cifuentes-Pagano; Daniel N Meijles; Patrick J Pagano
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 7.  Enzymatic regulation and functional relevance of NOX5.

Authors:  Feng Chen; Yusi Wang; Scott Barman; David J R Fulton
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

8.  Inhibiting the Activity of NADPH Oxidase in Cancer.

Authors:  Mariam M Konaté; Smitha Antony; James H Doroshow
Journal:  Antioxid Redox Signal       Date:  2020-04-17       Impact factor: 8.401

9.  Down-regulation of NOX2 activity in phagocytes mediated by ATM-kinase dependent phosphorylation.

Authors:  Sylvain Beaumel; Antoine Picciocchi; Franck Debeurme; Corinne Vivès; Anne-Marie Hesse; Myriam Ferro; Didier Grunwald; Heather Stieglitz; Pahk Thepchatri; Susan M E Smith; Franck Fieschi; Marie José Stasia
Journal:  Free Radic Biol Med       Date:  2017-09-13       Impact factor: 7.376

10.  Crystal structures and atomic model of NADPH oxidase.

Authors:  Francesca Magnani; Simone Nenci; Elisa Millana Fananas; Marta Ceccon; Elvira Romero; Marco W Fraaije; Andrea Mattevi
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.